Menu Display

Breadcrumb

Reimagining Cancer Care: Why We Can Not Accept the Status Quo

Working at Daiichi Sankyo, cancer was part of my everyday life. But this was different. This was my dad, and it was a diagnosis I knew would not end with the ringing of a bell…

 

Category Filter

Asset Publisher

Biomarker Testing and the Power of Information
Biomarker Testing and the Power of Information

Cancer remains one of the most challenging diseases in the world today, but critical advances in science are transforming options for more personalized treatment.

The Crafts Driving Our Pipeline Forward—Innovation, Resilience and Leadership
The Crafts Driving Our Pipeline Forward—Innovation, Resilience and Leadership

A career of building hope for people with cancer began with a single childhood moment for our Vice President, Global Team Leader, Oncology Research & Development, Dalila Sellami, MD.

Caring for a Cancer Patient, I Learned My Craft—Listening
Caring for a Cancer Patient, I Learned My Craft—Listening

As a teenager volunteering at a hospital, Simon King, Chief People Officer at Daiichi Sankyo, Inc., learned the difference between listening with his ears and listening with his heart.

The Critical Role of Biomarker Testing in Lung Cancer
The Critical Role of Biomarker Testing in Lung Cancer

Daiichi Sankyo supports “No One Missed” campaign to build awareness, empower patients and break down barriers to this essential step in cancer care.

How I Serve Patients Through a Culture of Learning
How I Serve Patients Through a Culture of Learning

As a champion of continuous learning, John Ruggiero, Ph.D., leverages the power of diverse voices to create better tomorrows for patients.

Though Born in Germany, Japan is Now “Home” for R&D Leader
Though Born in Germany, Japan is Now “Home” for R&D Leader

In Japanese, the word for home is uchi, うち. For Gerold Meinhardt, M.D., Ph.D., a German native living in the U.S., his true uchi is Japan.